KIRA TELLACHE: Open Payments
NPI 1104441021 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,747 in 93 payments from 15 companies in 2025. Trend: 2023 $1,249 · 2024 $2,992 · 2025 $2,747
Food & beverage: $2,567Education: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $577 |
| Janssen Biotech, Inc. | 17 | $395 |
| Regeneron Healthcare Solutions, Inc. | 9 | $287 |
| Galderma Laboratories, L.P. | 7 | $272 |
| Arcutis Biotherapeutics, Inc. | 7 | $227 |
| GENZYME CORPORATION | 7 | $215 |
| Amgen Inc. | 6 | $179 |
| Organon LLC | 1 | $141 |
| Incyte Corporation | 5 | $131 |
| LEO Pharma Inc. | 4 | $110 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, BOTOX, Zoryve, VTAMA, OPZELURA, CIBINQO.
Industry payments across CA — which companies pay providers there.
